{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:30Z","timestamp":1707524490945},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.7759\/cureus.20109","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T18:27:10Z","timestamp":1638469630000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Cachexia Associated With Valvular Heart Failure"],"prefix":"10.7759","author":[{"given":"Miguel A","family":"Rodriguez-Guerra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelanjana","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J","family":"Vittorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2008.10.012","article-title":"The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members","volume":"46","author":"Reid J","year":"2009","unstructured":"Reid J, McKenna H, Fitzsimons D, McCance T. The experience of cancer cachexia: a qualitative study of advanced cancer patients and their family members. Int J Nurs Stud. 2009, 46:606-16. 10.1016\/j.ijnurstu.2008.10.012","journal-title":"Int J Nurs Stud"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2009.01124.x","article-title":"An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals","volume":"19","author":"Reid J","year":"2010","unstructured":"Reid J, McKenna HP, Fitzsimons D, McCance TV. An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals. Eur J Cancer Care (Engl). 2010, 19:682-9. 10.1111\/j.1365-2354.2009.01124.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling S","year":"2014","unstructured":"von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014, 5:261-3. 10.1007\/s13539-014-0164-8","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume":"5","author":"Morley JE","year":"2014","unstructured":"Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle. 2014, 5:253-9. 10.1007\/s13539-014-0161-y","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-014-0158-6","article-title":"Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention","volume":"5","author":"Anker SD","year":"2014","unstructured":"Anker SD, von Haehling S. Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention. J Cachexia Sarcopenia Muscle. 2014, 5:171-6. 10.1007\/s13539-014-0158-6","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4065\/72.5.453","article-title":"Congestive heart failure in elderly patients","volume":"72","author":"Senni M","year":"1997","unstructured":"Senni M, Redfield MM. Congestive heart failure in elderly patients. Mayo Clin Proc. 1997, 72:453-60. 10.4065\/72.5.453","journal-title":"Mayo Clin Proc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20160142","article-title":"Cardiac cachexia: perspectives for prevention and treatment","volume":"108","author":"Okoshi MP","year":"2017","unstructured":"Okoshi MP, Capalbo RV, Romeiro FG, Okoshi K. Cardiac cachexia: perspectives for prevention and treatment. Arq Bras Cardiol. 2017, 108:74-80. 10.5935\/abc.20160142","journal-title":"Arq Bras Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12170-013-0353-6","article-title":"New approaches to treating cardiac cachexia in the older patient","volume":"7","author":"Azhar G","year":"2013","unstructured":"Azhar G, Wei JY. New approaches to treating cardiac cachexia in the older patient. Curr Cardiovasc Risk Rep. 2013, 7:480-4. 10.1007\/s12170-013-0353-6","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"ref9","article-title":"Falls in older persons: risk factors and prevention","author":"Institute of Medicine (US) Division of Health Promotion and Disease Prevention","year":"1992","unstructured":"Institute of Medicine (US) Division of Health Promotion and Disease Prevention. Falls in older persons: risk factors and prevention. The second fifty years: promoting health and preventing disability. Berg RL, Cassells JS (ed): National Academies Press, Washington, DC; 1992. 15:"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-010-0841-y","article-title":"Gender differences in coronary heart disease","volume":"18","author":"Maas AH","year":"2010","unstructured":"Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010, 18:598-602. 10.1007\/s12471-010-0841-y","journal-title":"Neth Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000221585.94490.09","article-title":"Prognosis and therapy approaches of cardiac cachexia","volume":"21","author":"Springer J","year":"2006","unstructured":"Springer J, Filippatos G, Akashi YJ, Anker SD. Prognosis and therapy approaches of cardiac cachexia. Curr Opin Cardiol. 2006, 21:229-33. 10.1097\/01.hco.0000221585.94490.09","journal-title":"Curr Opin Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-013-0153-9","article-title":"Mechanisms for cachexia in heart failure","volume":"10","author":"Pureza V","year":"2013","unstructured":"Pureza V, Florea VG. Mechanisms for cachexia in heart failure. Curr Heart Fail Rep. 2013, 10:307-14. 10.1007\/s11897-013-0153-9","journal-title":"Curr Heart Fail Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans WJ","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J, et al.. Cachexia: a new definition. Clin Nutr. 2008, 27:793-9. 10.1016\/j.clnu.2008.06.013","journal-title":"Clin Nutr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker SD","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJ, et al.. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003, 361:1077-1083. 10.1016\/S0140-6736(03)12892-9","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2014.09.007","article-title":"Treatment of cachexia: an overview of recent developments","volume":"15","author":"von Haehling S","year":"2014","unstructured":"von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc. 2014, 15:866-72. 10.1016\/j.jamda.2014.09.007","journal-title":"J Am Med Dir Assoc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S273967","article-title":"Cardiac cachexia: a well-known but challenging complication of heart failure","volume":"15","author":"Krysztofiak H","year":"2020","unstructured":"Krysztofiak H, Wleklik M, Migaj J, et al.. Cardiac cachexia: a well-known but challenging complication of heart failure. Clin Interv Aging. 2020, 15:2041-51. 10.2147\/CIA.S273967","journal-title":"Clin Interv Aging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.03.002","article-title":"Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure","volume":"6","author":"Krack A","year":"2004","unstructured":"Krack A, Richartz BM, Gastmann A, Greim K, Lotze U, Anker SD, Figulla HR. Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure. Eur J Heart Fail. 2004, 6:403-7. 10.1016\/j.ejheart.2004.03.002","journal-title":"Eur J Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram V","year":"2016","unstructured":"Sundaram V, Fang JC. Gastrointestinal and liver issues in heart failure. Circulation. 2016, 133:1696-703. 10.1161\/CIRCULATIONAHA.115.020894","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018549","article-title":"Interleukin 6 and development of heart failure with preserved ejection fraction in the general population","volume":"10","author":"Chia YC","year":"2021","unstructured":"Chia YC, Kieneker LM, van Hassel G, et al.. Interleukin 6 and development of heart failure with preserved ejection fraction in the general population. J Am Heart Assoc. 2021, 10:e018549. 10.1161\/JAHA.120.018549","journal-title":"J Am Heart Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2019.32748","article-title":"Role of interleukins in heart failure with reduced ejection fraction","volume":"22","author":"Segiet OA","year":"2019","unstructured":"Segiet OA, Piecuch A, Mielanczyk L, Michalski M, Nowalany-Kozielska E. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 2019, 22:287-99. 10.14744\/AnatolJCardiol.2019.32748","journal-title":"Anatol J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal A","year":"2001","unstructured":"Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001, 103:2055-9. 10.1161\/01.cir.103.16.2055","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0159","article-title":"Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure","volume":"34","author":"Liu Q","year":"2014","unstructured":"Liu Q, Wang T, Yu H, Liu B, Jia R. Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure. J Interferon Cytokine Res. 2014, 34:870-5. 10.1089\/jir.2013.0159","journal-title":"J Interferon Cytokine Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: a paradigm for cytokines","volume":"258","author":"Kishimoto T","year":"1992","unstructured":"Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992, 258:593-7. 10.1126\/science.1411569","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft067","article-title":"Increased catabolic activity in adipose tissue of patients with chronic heart failure","volume":"15","author":"Szab\u00f3 T","year":"2013","unstructured":"Szab\u00f3 T, Postrach E, M\u00e4hler A, et al.. Increased catabolic activity in adipose tissue of patients with chronic heart failure. Eur J Heart Fail. 2013, 15:1131-7. 10.1093\/eurjhf\/hft067","journal-title":"Eur J Heart Fail"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione G","year":"1996","unstructured":"Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996, 27:1201-6. 10.1016\/0735-1097(95)00589-7","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.JCN.0000305093.20012.b8","article-title":"Family influences on heart failure self-care and outcomes","volume":"23","author":"Dunbar SB","year":"2008","unstructured":"Dunbar SB, Clark PC, Quinn C, Gary RA, Kaslow NJ. Family influences on heart failure self-care and outcomes. J Cardiovasc Nurs. 2008, 23:258-65. 10.1097\/01.JCN.0000305093.20012.b8","journal-title":"J Cardiovasc Nurs"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.07.042","article-title":"Positive psychological well-being and cardiovascular disease: JACC health promotion series","volume":"72","author":"Kubzansky LD","year":"2018","unstructured":"Kubzansky LD, Huffman JC, Boehm JK, et al.. Positive psychological well-being and cardiovascular disease: JACC health promotion series. J Am Coll Cardiol. 2018, 72:1382-96. 10.1016\/j.jacc.2018.07.042","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.12.030","article-title":"Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades","volume":"167","author":"Coffey S","year":"2014","unstructured":"Coffey S, Cox B, Williams MJ. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades. Am Heart J. 2014, 167:562-7.e2. 10.1016\/j.ahj.2013.12.030","journal-title":"Am Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.10.020404","article-title":"Burden of valvular heart disease, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"10","author":"Chen J","year":"2020","unstructured":"Chen J, Li W, Xiang M. Burden of valvular heart disease, 1990-2017: results from the Global Burden of Disease Study 2017. J Glob Health. 2020, 10:020404. 10.7189\/jogh.10.020404","journal-title":"J Glob Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.05.022","article-title":"Valvular heart disease: classic teaching and emerging paradigms","volume":"126","author":"Brinkley DM","year":"2013","unstructured":"Brinkley DM, Gelfand EV. Valvular heart disease: classic teaching and emerging paradigms. Am J Med. 2013, 126:1035-42. 10.1016\/j.amjmed.2013.05.022","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.6292","article-title":"Mortality due to aortic stenosis in the United States, 2008-2017","volume":"321","author":"Bevan GH","year":"2019","unstructured":"Bevan GH, Zidar DA, Josephson RA, Al-Kindi SG. Mortality due to aortic stenosis in the United States, 2008-2017. JAMA. 2019, 321:2236-8. 10.1001\/jama.2019.6292","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-13-3-126","article-title":"Transcatheter valve replacement: risk levels and contemporary outcomes","volume":"13","author":"Reyes M","year":"2017","unstructured":"Reyes M, Reardon MJ. Transcatheter valve replacement: risk levels and contemporary outcomes. Methodist Debakey Cardiovasc J. 2017, 13:126-31. 10.14797\/mdcj-13-3-126","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008331","article-title":"Impact of ischemic and valvular heart disease on atrial excitation:a high-resolution epicardial mapping study","volume":"7","author":"Mouws EM","year":"2018","unstructured":"Mouws EM, Lanters EA, Teuwen CP, et al.. Impact of ischemic and valvular heart disease on atrial excitation:a high-resolution epicardial mapping study. J Am Heart Assoc. 2018, 7:e008331. 10.1161\/JAHA.117.008331","journal-title":"J Am Heart Assoc"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0706","article-title":"Valvular heart disease: diagnosis and management","volume":"85","author":"Maganti K","year":"2010","unstructured":"Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010, 85:483-500. 10.4065\/mcp.2009.0706","journal-title":"Mayo Clin Proc"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytab089","article-title":"Concept of myocardial fatigue in reversible severe left ventricular systolic dysfunction from afterload mismatch: a case series","volume":"5","author":"Tran P","year":"2021","unstructured":"Tran P, Joshi M, Banerjee P. Concept of myocardial fatigue in reversible severe left ventricular systolic dysfunction from afterload mismatch: a case series. Eur Heart J Case Rep. 2021, 5:ytab089. 10.1093\/ehjcr\/ytab089","journal-title":"Eur Heart J Case Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10047-013-0730-4","article-title":"Left ventricular performance after aortic valve replacement in patients with low ejection fraction","volume":"16","author":"Tanoue Y","year":"2013","unstructured":"Tanoue Y, Oishi Y, Sonoda H, Nishida T, Nakashima A, Tominaga R. Left ventricular performance after aortic valve replacement in patients with low ejection fraction. J Artif Organs. 2013, 16:443-50. 10.1007\/s10047-013-0730-4","journal-title":"J Artif Organs"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell BH","year":"2000","unstructured":"Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000, 102:470-9. 10.1161\/01.cir.102.4.470","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.466","article-title":"Diagnosis and management of aortic valve stenosis in patients with heart failure","volume":"18","author":"Kamperidis V","year":"2016","unstructured":"Kamperidis V, Delgado V, van Mieghem NM, Kappetein AP, Leon MB, Bax JJ. Diagnosis and management of aortic valve stenosis in patients with heart failure. Eur J Heart Fail. 2016, 18:469-81. 10.1002\/ejhf.466","journal-title":"Eur J Heart Fail"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.oa.16-00165","article-title":"Long-term outcomes of conventional aortic valve replacement in high-risk patients: where do we stand?","volume":"22","author":"Nicolini F","year":"2016","unstructured":"Nicolini F, Fortuna D, Contini GA, Pacini D, Gabbieri D, De Palma R, Gherli T. Long-term outcomes of conventional aortic valve replacement in high-risk patients: where do we stand?. Ann Thorac Cardiovasc Surg. 2016, 22:304-11. 10.5761\/atcs.oa.16-00165","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccl.2020.07.002","article-title":"A review of the Partner trials","volume":"9","author":"Markham R","year":"2020","unstructured":"Markham R, Sharma R. A review of the Partner trials. Interv Cardiol Clin. 2020, 9:461-7. 10.1016\/j.iccl.2020.07.002","journal-title":"Interv Cardiol Clin"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.11.051","article-title":"A comprehensive review of the PARTNER trial","volume":"145","author":"Svensson LG","year":"2013","unstructured":"Svensson LG, Tuzcu M, Kapadia S, et al.. A comprehensive review of the PARTNER trial. J Thorac Cardiovasc Surg. 2013, 145:S11-6. 10.1016\/j.jtcvs.2012.11.051","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.06.32","article-title":"Aortic valve replacement in patients with a left ventricular ejection fraction \u226435% performed via a minimally invasive right thoracotomy","volume":"9","author":"Santana O","year":"2017","unstructured":"Santana O, Xydas S, Williams RF, et al.. Aortic valve replacement in patients with a left ventricular ejection fraction \u226435% performed via a minimally invasive right thoracotomy. J Thorac Dis. 2017, 9:S607-13. 10.21037\/jtd.2017.06.32","journal-title":"J Thorac Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.4320","article-title":"Outcomes from transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and left ventricular ejection fraction less than 30%: a substudy from the Topas-Tavi registry","volume":"4","author":"Maes F","year":"2019","unstructured":"Maes F, Lerakis S, Barbosa Ribeiro H, et al.. Outcomes from transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and left ventricular ejection fraction less than 30%: a substudy from the Topas-Tavi registry. JAMA Cardiol. 2019, 4:64-70. 10.1001\/jamacardio.2018.4320","journal-title":"JAMA Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76381-cardiac-cachexia-associated-with-valvular-heart-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:51Z","timestamp":1707507111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76381-cardiac-cachexia-associated-with-valvular-heart-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.20109","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}